Receptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection

Middle East respiratory syndrome (MERS) continues to raise worldwide concerns due to its pandemic potential. Increased MERS cases and no licensed MERS vaccines highlight the need to develop safe and effective vaccines against MERS. We have previously demonstrated that a receptor-binding domain (RBD)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hum Vaccin Immunother
Autori principali: Wang, Yufei, Tai, Wanbo, Yang, Jie, Zhao, Guangyu, Sun, Shihui, Tseng, Chien-Te K., Jiang, Shibo, Zhou, Yusen, Du, Lanying, Gao, Jimin
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2017
Soggetti:
Research Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512770/
https://ncbi.nlm.nih.gov/pubmed/28277821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1296994
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi